Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 611

1.

Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.

Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P.

Liver Transpl. 2007 May;13(5):687-92.

2.

Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.

Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE.

Liver Transpl. 2009 Dec;15(12):1872-81. doi: 10.1002/lt.21954.

3.

Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.

Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, Hosny A, Marawan I, El-Malt O, Kamel RR, Hatata Y, Ghali A, Sabri H, Kamel S, El-Gbaly H, Tanaka K.

Transplant Proc. 2008 Jun;40(5):1481-4. doi: 10.1016/j.transproceed.2008.03.085.

PMID:
18589133
4.

Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.

Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, Oike F, Ueda M, Egawa H, Tanaka K.

Transplantation. 2006 Feb 15;81(3):350-4.

PMID:
16477219
5.

Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.

Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE.

Liver Transpl. 2006 Apr;12(4):560-5.

6.

Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation.

Lawal A, Ghobrial R, Te H, Artinian L, Eastwood D, Schiano TD.

Transplant Proc. 2007 Dec;39(10):3261-5.

PMID:
18089367
7.

Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.

Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell A, Maluf D, Posner MP, Fisher RA.

Liver Transpl. 2004 Oct;10(10):1248-55.

8.

HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.

De Martin E, Senzolo M, Boninsegna S, Guido M, Masier A, Germani G, Tomat S, Brolese A, Neri D, Cillo U, Gambato M, Russo FP, Farinati F, Burra P.

Transplant Proc. 2008 Jul-Aug;40(6):1974-5. doi: 10.1016/j.transproceed.2008.05.040.

PMID:
18675104
9.

The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.

Selzner N, Girgrah N, Lilly L, Guindi M, Selzner M, Therapondos G, Adeyi O, McGilvray I, Cattral M, Greig PD, Grant D, Levy G, Renner EL.

Liver Transpl. 2008 Dec;14(12):1778-86. doi: 10.1002/lt.21598.

10.

Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.

Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.

Liver Transpl. 2007 Jun;13(6):807-13.

11.

Liver transplantation in the United States.

Qiu J, Ozawa M, Terasaki PI.

Clin Transpl. 2005:17-28.

PMID:
17424722
12.

A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.

Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, McGilvray ID, Therapondos G, Adcock LE, Ghanekar A, Levy GA, Renner EL, Grant DR.

Liver Transpl. 2009 Dec;15(12):1776-82. doi: 10.1002/lt.21955.

13.

Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.

Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS.

Transplantation. 2011 Aug 27;92(4):453-60. doi: 10.1097/TP.0b013e3182259282.

PMID:
21799468
15.

Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?

Moya A, Berenguer M, Aguilera V, Juan FS, Nicolás D, Pastor M, López-Andujar R, Rayón M, Orbis F, Mora J, De Juan M, Carrasco D, Vila JJ, Prieto M, Berenguer J, Mir J.

Liver Transpl. 2002 Nov;8(11):1020-7.

16.

Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.

Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, Schiano TD.

Liver Transpl. 2006 Oct;12(10):1496-503.

17.

Is recurrent hepatitis C worse with living donors?

Kuo A, Terrault NA.

Curr Opin Organ Transplant. 2009 Jun;14(3):240-4. doi: 10.1097/MOT.0b013e32832b1f1d. Review.

PMID:
19395968
18.

Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors.

Schiano TD, Gutierrez JA, Walewski JL, Fiel MI, Cheng B, Bodenheimer H Jr, Thung SN, Chung RT, Schwartz ME, Bodian C, Branch AD.

Hepatology. 2005 Dec;42(6):1420-8.

PMID:
16317672
19.

Living donor and split-liver transplants in hepatitis C recipients: does liver regeneration increase the risk for recurrence?

Humar A, Horn K, Kalis A, Glessing B, Payne WD, Lake J.

Am J Transplant. 2005 Feb;5(2):399-405.

20.

Liver transplantation using donors older than 80 years: a single-center experience.

Petridis I, Gruttadauria S, Nadalin S, Viganò J, di Francesco F, Pietrosi G, Fili' D, Montalbano M, D'Antoni A, Volpes R, Arcadipane A, Vizzini G, Gridelli B.

Transplant Proc. 2008 Jul-Aug;40(6):1976-8. doi: 10.1016/j.transproceed.2008.05.063.

PMID:
18675105
Items per page

Supplemental Content

Support Center